Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (281-290 of 432) with videos related to

Pageof 44
Sort By:
Annals of Surgery|August 1, 1993
Increased bile duct complications in liver transplantation across the ABO barrierL Sanchez-Urdazpal, K P Batts, G J Gores, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 1, 1997
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506)V J Canzanello, L Schwartz, S J Taler, et al.
The American Journal of Gastroenterology|March 30, 2004
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitisK V Narayanan Menon, Linda Stadheim, Patrick S Kamath, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2007
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantationPhunchai Charatcharoenwitthaya, Sylvania Pimentel, Jayant A Talwalkar, et al.
The New England Journal of Medicine|May 17, 1990
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosisR H Wiesner, J Ludwig, K D Lindor, et al.
Transplantation Proceedings|February 1, 1987
Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantationJ Rakela, R H Wiesner, H F Taswell, et al.
Transplantation Proceedings|March 20, 1999
Kupffer cell expression of CD40L (CD154) in human chronic liver allograft rejectionA S Gaweco, R H Wiesner, S Yong, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Liver and intestine transplantationJohn P Roberts, Robert S Brown, Erick B Edwards, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
CD40L (CD154) expression in human liver allografts during chronic ductopenic rejectionA S Gaweco, R H Wiesner, S Yong, et al.
Pageof 44

Showing results (281-290 of 432) with videos related to

Sort By:
Pageof 44
Annals of Surgery|August 1, 1993
Increased bile duct complications in liver transplantation across the ABO barrierL Sanchez-Urdazpal, K P Batts, G J Gores, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 1, 1997
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506)V J Canzanello, L Schwartz, S J Taler, et al.
The American Journal of Gastroenterology|March 30, 2004
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitisK V Narayanan Menon, Linda Stadheim, Patrick S Kamath, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2007
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantationPhunchai Charatcharoenwitthaya, Sylvania Pimentel, Jayant A Talwalkar, et al.
The New England Journal of Medicine|May 17, 1990
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosisR H Wiesner, J Ludwig, K D Lindor, et al.
Transplantation Proceedings|February 1, 1987
Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantationJ Rakela, R H Wiesner, H F Taswell, et al.
Transplantation Proceedings|March 20, 1999
Kupffer cell expression of CD40L (CD154) in human chronic liver allograft rejectionA S Gaweco, R H Wiesner, S Yong, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2003
Liver and intestine transplantationJohn P Roberts, Robert S Brown, Erick B Edwards, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
CD40L (CD154) expression in human liver allografts during chronic ductopenic rejectionA S Gaweco, R H Wiesner, S Yong, et al.
Pageof 44